erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Lacrimal Duct Obstruction D007767 1 associated lipids
Choanal Atresia D002754 1 associated lipids
Scarlet Fever D012541 1 associated lipids
Pilonidal Sinus D010864 1 associated lipids
Postoperative Nausea and Vomiting D020250 1 associated lipids
Vagus Nerve Injuries D061223 1 associated lipids
Focal Infection, Dental D005491 1 associated lipids
Maxillofacial Injuries D008446 1 associated lipids
Dacryocystitis D003607 1 associated lipids
Erythrasma D004894 1 associated lipids
Granuloma, Respiratory Tract D015769 1 associated lipids
Jaw Abnormalities D007569 1 associated lipids
Lymphoma, B-Cell, Marginal Zone D018442 1 associated lipids
Sialadenitis D012793 1 associated lipids
Actinomycosis, Cervicofacial D000197 1 associated lipids
Pericarditis, Constrictive D010494 1 associated lipids
Microphthalmos D008850 1 associated lipids
Peritonsillar Abscess D000039 1 associated lipids
Staphylococcal Scalded Skin Syndrome D013206 1 associated lipids
Skin Diseases, Vascular D017445 1 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Kishi K et al. [Study of efficacy of macrolide therapy applied to Kartagener's syndrome]. 1998 Jpn J Antibiot pmid:9597497
Miyazawa T et al. [Mucous pathology and macrolide treatment of paranasal sinusitis in children]. 1998 Jpn J Antibiot pmid:9597499
Okura M et al. [Multicenter study on clinical effects of a small dose of erythromycin on chronic lung disorders of premature infants--single blind comparison of treated and untreated groups. A committee for the Study of EM Therapy for Chronic Lung Diseases of Premature Infants]. 1998 Jpn J Antibiot pmid:9597500
Nishimura J et al. [Effects of erythromycin on Pseudomonas aeruginosa pyocyanine-induced IL-8 production and its biological activity (the 2nd report)]. 1998 Jpn J Antibiot pmid:9597503
Abe S et al. [Effect of macrolides on IL-8 gene expression by cultured airway epithelial cells]. 1998 Jpn J Antibiot pmid:9597504
Sugiyama Y et al. [Changes in cytokine production by pulmonary alveolar macrophages collected from rats that have been treated with erythromycin for an extended period]. 1998 Jpn J Antibiot pmid:9597506
Yoshimine H et al. [Inhibition of neutrophil-derived IL-8 production caused by EM (erythromycin) 201 derivative: modification of the activities by the 5-position desosamine side chain]. 1998 Jpn J Antibiot pmid:9597508
Kozeki S et al. [Study on bacterial biofilm destruction by various antibacterial agents]. 1998 Jpn J Antibiot pmid:9597510
Nakada M et al. [Inhibitory effects of macrolide antibiotics at low concentrations on vero toxin production by pathogenic E. coli O157]. 1998 Jpn J Antibiot pmid:9597511
Kyo S et al. [Effects of macrolides on intracellular Ca2+ response by airway epithelium]. 1998 Jpn J Antibiot pmid:9597513
Tanabe O et al. [Mechanism of erythromycin action on gene expression of airway epithelial cells]. 1998 Jpn J Antibiot pmid:9597514
Muranaka H et al. [Superoxide radical scavenging activity of an erythromycin-iron complex (the second report)]. 1998 Jpn J Antibiot pmid:9597516
Ng P et al. Diffuse panbronchiolitis: case report and review of the literature. 1998 Australas Radiol pmid:9599832
Karrer S et al. [Acne comedonica following radiation therapy]. 1998 Dtsch. Med. Wochenschr. pmid:9601475
Farrell AM et al. Pyoderma gangrenosum of the penis. 1998 Br. J. Dermatol. pmid:9602887
Vachálková A and Novotný L Polarographic testing of carcinogenicity of some chemotherapeutics. 1997 Neoplasma pmid:9605013
Paesen J et al. Study of the stability of erythromycin in a hydrophilic creme basis by liquid chromatography. 1998 J Pharm Biomed Anal pmid:9608426
Kudoh S Erythromycin treatment in diffuse panbronchiolitis. 1998 Curr Opin Pulm Med pmid:9612675
Neubrand M and Sauerbruch T Erythromycin, a motilin agonist, increases postprandial gallbladder emptying during therapy with ursodeoxycholic acid. 1998 Z Gastroenterol pmid:9612923
Gaisser S et al. Analysis of eryBI, eryBIII and eryBVII from the erythromycin biosynthetic gene cluster in Saccharopolyspora erythraea. 1998 Mol. Gen. Genet. pmid:9613575